RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
United Laboratories International Holdings Stock

United Laboratories International Holdings Net Income 2024

United Laboratories International Holdings Net Income

2.88 B CNY

Ticker

3933.HK

ISIN

KYG8813K1085

WKN

A0MUFS

In 2024, United Laboratories International Holdings's profit amounted to 2.88 B CNY, a 6.45% increase from the 2.7 B CNY profit recorded in the previous year.

The United Laboratories International Holdings Net Income history

YEARNET INCOME (undefined CNY)
2026e3
2025e2.85
2024e2.88
20232.7
20221.58
20210.99
20200.7
20190.64
20180.68
20170.08
2016-0.27
20150.1
20140.61
20130.04
20120.13
20110.09
20100.85
20090.48
20080.38
20070.5
20060.18
20050.12
20040.14

United Laboratories International Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into United Laboratories International Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by United Laboratories International Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects United Laboratories International Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of United Laboratories International Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into United Laboratories International Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing United Laboratories International Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on United Laboratories International Holdings’s growth potential.

United Laboratories International Holdings Revenue, EBIT and net profit per share

DateUnited Laboratories International Holdings RevenueUnited Laboratories International Holdings EBITUnited Laboratories International Holdings Net Income
2026e16.78 B undefined3.37 B undefined3 B undefined
2025e15.93 B undefined3.28 B undefined2.85 B undefined
2024e15.19 B undefined3.38 B undefined2.88 B undefined
202313.74 B undefined3.28 B undefined2.7 B undefined
202211.33 B undefined2.11 B undefined1.58 B undefined
20219.7 B undefined1.16 B undefined988.1 M undefined
20208.77 B undefined1.25 B undefined702.99 M undefined
20198.39 B undefined1.08 B undefined641.76 M undefined
20187.51 B undefined1.01 B undefined682.93 M undefined
20176.83 B undefined689.11 M undefined81.76 M undefined
20166.08 B undefined408.18 M undefined-272.36 M undefined
20156.74 B undefined741.62 M undefined96.69 M undefined
20147.19 B undefined1.29 B undefined609.78 M undefined
20136.06 B undefined409.2 M undefined38.1 M undefined
20125.71 B undefined315.8 M undefined131.7 M undefined
20115.32 B undefined276.1 M undefined86.6 M undefined
20105.67 B undefined1.08 B undefined848.8 M undefined
20094.09 B undefined706.4 M undefined477.1 M undefined
20083.35 B undefined559 M undefined383.9 M undefined
20072.53 B undefined613.6 M undefined497.6 M undefined
20062.13 B undefined305 M undefined178.4 M undefined
20051.81 B undefined243.4 M undefined122.7 M undefined
20041.28 B undefined212.6 M undefined140.4 M undefined

United Laboratories International Holdings stock margins

The United Laboratories International Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of United Laboratories International Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for United Laboratories International Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the United Laboratories International Holdings's sales revenue. A higher gross margin percentage indicates that the United Laboratories International Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the United Laboratories International Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the United Laboratories International Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the United Laboratories International Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the United Laboratories International Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the United Laboratories International Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

United Laboratories International Holdings Margin History

United Laboratories International Holdings Gross marginUnited Laboratories International Holdings Profit marginUnited Laboratories International Holdings EBIT marginUnited Laboratories International Holdings Profit margin
2026e46.11 %20.09 %17.91 %
2025e46.11 %20.56 %17.91 %
2024e46.11 %22.28 %18.93 %
202346.11 %23.89 %19.66 %
202243.84 %18.58 %13.95 %
202143.4 %11.95 %10.18 %
202043.39 %14.26 %8.01 %
201943.15 %12.87 %7.65 %
201840.64 %13.39 %9.09 %
201736.6 %10.09 %1.2 %
201635.58 %6.72 %-4.48 %
201538.48 %11 %1.43 %
201440.2 %17.97 %8.48 %
201334.49 %6.75 %0.63 %
201230.15 %5.53 %2.31 %
201128.55 %5.19 %1.63 %
201039.49 %18.98 %14.98 %
200939.07 %17.26 %11.66 %
200838.06 %16.68 %11.45 %
200746.47 %24.26 %19.67 %
200635.39 %14.29 %8.36 %
200534.86 %13.43 %6.77 %
200433.21 %16.67 %11.01 %

United Laboratories International Holdings Aktienanalyse

What does United Laboratories International Holdings do?

United Laboratories International Holdings Ltd is a leading research and development company specializing in innovative and high-quality health, beauty, and wellness products for people worldwide. The company was founded in 1961 and is headquartered in Hong Kong, China. United Laboratories International Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding United Laboratories International Holdings's Profit Margins

The profit margins of United Laboratories International Holdings represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of United Laboratories International Holdings's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating United Laboratories International Holdings's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

United Laboratories International Holdings's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When United Laboratories International Holdings’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about United Laboratories International Holdings stock

How much profit has United Laboratories International Holdings made this year?

United Laboratories International Holdings has made 2.88 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by 6.45% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does United Laboratories International Holdings publish its earnings?

United Laboratories International Holdings publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of United Laboratories International Holdings?

The profits of United Laboratories International Holdings are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of United Laboratories International Holdings?

You can learn more about the earnings of United Laboratories International Holdings by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does United Laboratories International Holdings pay?

Over the past 12 months, United Laboratories International Holdings paid a dividend of 0.28 CNY . This corresponds to a dividend yield of about 3.54 %. For the coming 12 months, United Laboratories International Holdings is expected to pay a dividend of 0.32 CNY.

What is the dividend yield of United Laboratories International Holdings?

The current dividend yield of United Laboratories International Holdings is 3.54 %.

When does United Laboratories International Holdings pay dividends?

United Laboratories International Holdings pays a quarterly dividend. This is distributed in the months of October, July, August, October.

How secure is the dividend of United Laboratories International Holdings?

United Laboratories International Holdings paid dividends every year for the past 9 years.

What is the dividend of United Laboratories International Holdings?

For the upcoming 12 months, dividends amounting to 0.32 CNY are expected. This corresponds to a dividend yield of 3.96 %.

In which sector is United Laboratories International Holdings located?

United Laboratories International Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von United Laboratories International Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of United Laboratories International Holdings from 11/1/2024 amounting to 0.16 CNY, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did United Laboratories International Holdings pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of United Laboratories International Holdings in the year 2023?

In the year 2023, United Laboratories International Holdings distributed 0.15 CNY as dividends.

In which currency does United Laboratories International Holdings pay out the dividend?

The dividends of United Laboratories International Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von United Laboratories International Holdings

Our stock analysis for United Laboratories International Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of United Laboratories International Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.